Company Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific.

It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates.

The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.

It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Corporation

Country	United States
Industry	Biotechnology
Sector	Healthcare
Employees	13
CEO	Owen P. Hughes Jr.

Contact Details

Address: 2200 Powell Street, Suite 310 Emeryville, California 94608 United States
Phone	510-204-7239
Website	xoma.com

Stock Details

Ticker Symbol	XOMA
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0000791908
CUSIP Number	98419J206
ISIN Number	US98419J2069
Employer ID	52-2154066
SIC Code	2834

Key Executives

Name	Position
Owen P. Hughes Jr.	Chief Executive Officer and Director
Thomas M. Burns	Senior Vice President of Finance and Chief Financial Officer
Brad Sitko	Chief Investment Officer

Latest SEC Filings

Date	Type	Title
Apr 25, 2024	8-K	Current Report
Apr 3, 2024	8-K	Current Report
Apr 2, 2024	ARS	Filing
Apr 2, 2024	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 2, 2024	DEF 14A	Other definitive proxy statements
Mar 8, 2024	S-4	Filing
Mar 8, 2024	S-3	Registration statement under Securities Act of 1933
Mar 8, 2024	10-K	Annual Report
Mar 8, 2024	8-K	Current Report
Feb 16, 2024	8-K	Current Report

View All SEC Filings